Would the occurrence of obvious tumor rupture/spillage intraoperatively impact your decision for adjuvant systemic therapy after resection of either clear cell RCC or papillary RCC?

Would you consider Nivo/Ipi or IO/TKI instead of simply adjuvant pembrolizumab in this scenario?